Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anne M Fagan

Showing results (231-240 of 279) with videos related to

Pageof 28
Sort By:
Nature|May 8, 2020
APOE4 leads to blood-brain barrier dysfunction predicting cognitive declineAxel Montagne, Daniel A Nation, Abhay P Sagare, et al.
Neurology|August 7, 2015
Cerebral amyloidosis associated with cognitive decline in autosomal dominant Alzheimer diseaseFen Wang, Brian A Gordon, Davis C Ryman, et al.
Clinical Investigation|November 10, 2012
Developing an international network for Alzheimer research: The Dominantly Inherited Alzheimer NetworkJohn C Morris, Paul S Aisen, Randall J Bateman, et al.
Brain : a Journal of Neurology|January 10, 2023
Brain network decoupling with increased serum neurofilament and reduced cognitive function in Alzheimer's diseaseMuriah D Wheelock, Jeremy F Strain, Patricia Mansfield, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 2, 2021
Different rates of cognitive decline in autosomal dominant and late-onset Alzheimer diseaseVirginia D Buckles, Chengjie Xiong, Randall J Bateman, et al.
The Lancet. Neurology|October 26, 2016
Neurological manifestations of autosomal dominant familial Alzheimer's disease: a comparison of the published literature with the Dominantly Inherited Alzheimer Network observational study (DIAN-OBS)Mengxuan Tang, Davis C Ryman, Eric McDade, et al.
The New England Journal of Medicine|July 13, 2012
Clinical and biomarker changes in dominantly inherited Alzheimer's diseaseRandall J Bateman, Chengjie Xiong, Tammie L S Benzinger, et al.
Neurobiology of Disease|March 31, 2022
CSF Tau phosphorylation at Thr205 is associated with loss of white matter integrity in autosomal dominant Alzheimer diseaseJeremy F Strain, Nicolas Barthelemy, Kanta Horie, et al.
The Lancet. Neurology|December 14, 2022
Comparison of amyloid burden in individuals with Down syndrome versus autosomal dominant Alzheimer's disease: a cross-sectional studyAnna H Boerwinkle, Brian A Gordon, Julie Wisch, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|November 9, 2022
Evaluation of dose-dependent treatment effects after mid-trial dose escalation in biomarker, clinical, and cognitive outcomes for gantenerumab or solanezumab in dominantly inherited Alzheimer's diseaseGuoqiao Wang, Yan Li, Chengjie Xiong, et al.
Pageof 28

Showing results (231-240 of 279) with videos related to

Sort By:
Pageof 28
Nature|May 8, 2020
APOE4 leads to blood-brain barrier dysfunction predicting cognitive declineAxel Montagne, Daniel A Nation, Abhay P Sagare, et al.
Neurology|August 7, 2015
Cerebral amyloidosis associated with cognitive decline in autosomal dominant Alzheimer diseaseFen Wang, Brian A Gordon, Davis C Ryman, et al.
Clinical Investigation|November 10, 2012
Developing an international network for Alzheimer research: The Dominantly Inherited Alzheimer NetworkJohn C Morris, Paul S Aisen, Randall J Bateman, et al.
Brain : a Journal of Neurology|January 10, 2023
Brain network decoupling with increased serum neurofilament and reduced cognitive function in Alzheimer's diseaseMuriah D Wheelock, Jeremy F Strain, Patricia Mansfield, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 2, 2021
Different rates of cognitive decline in autosomal dominant and late-onset Alzheimer diseaseVirginia D Buckles, Chengjie Xiong, Randall J Bateman, et al.
The Lancet. Neurology|October 26, 2016
Neurological manifestations of autosomal dominant familial Alzheimer's disease: a comparison of the published literature with the Dominantly Inherited Alzheimer Network observational study (DIAN-OBS)Mengxuan Tang, Davis C Ryman, Eric McDade, et al.
The New England Journal of Medicine|July 13, 2012
Clinical and biomarker changes in dominantly inherited Alzheimer's diseaseRandall J Bateman, Chengjie Xiong, Tammie L S Benzinger, et al.
Neurobiology of Disease|March 31, 2022
CSF Tau phosphorylation at Thr205 is associated with loss of white matter integrity in autosomal dominant Alzheimer diseaseJeremy F Strain, Nicolas Barthelemy, Kanta Horie, et al.
The Lancet. Neurology|December 14, 2022
Comparison of amyloid burden in individuals with Down syndrome versus autosomal dominant Alzheimer's disease: a cross-sectional studyAnna H Boerwinkle, Brian A Gordon, Julie Wisch, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|November 9, 2022
Evaluation of dose-dependent treatment effects after mid-trial dose escalation in biomarker, clinical, and cognitive outcomes for gantenerumab or solanezumab in dominantly inherited Alzheimer's diseaseGuoqiao Wang, Yan Li, Chengjie Xiong, et al.
Pageof 28